File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial

TitleFeasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
Authors
Johansen, NDModin, DNealon, JAPSamson, SSalamand, CLarsen, CSClaggett, BLSolomon, SDLandray, MJGislason, GHKober, LJensen, JUSSivapalan, PVestergaard, LSValentiner-Branth, PKrause, TGBiering-Sørensen, T
Issue Date2022
Citation
Pilot and Feasibility Studies, 2022, v. 8 n. 1, p. 87 How to Cite?
DOI: http://dx.doi.org/10.1186/s40814-022-01044-w
Persistent Identifierhttp://hdl.handle.net/10722/312716
ISI Accession Number ID
WOS:000784562400001

 

DC FieldValueLanguage
dc.contributor.authorJohansen, ND-
dc.contributor.authorModin, D-
dc.contributor.authorNealon, JAP-
dc.contributor.authorSamson, S-
dc.contributor.authorSalamand, C-
dc.contributor.authorLarsen, CS-
dc.contributor.authorClaggett, BL-
dc.contributor.authorSolomon, SD-
dc.contributor.authorLandray, MJ-
dc.contributor.authorGislason, GH-
dc.contributor.authorKober, L-
dc.contributor.authorJensen, JUS-
dc.contributor.authorSivapalan, P-
dc.contributor.authorVestergaard, LS-
dc.contributor.authorValentiner-Branth, P-
dc.contributor.authorKrause, TG-
dc.contributor.authorBiering-Sørensen, T-
dc.date.accessioned2022-05-12T10:54:35Z-
dc.date.available2022-05-12T10:54:35Z-
dc.date.issued2022-
dc.identifier.citationPilot and Feasibility Studies, 2022, v. 8 n. 1, p. 87-
dc.identifier.urihttp://hdl.handle.net/10722/312716-
dc.languageeng-
dc.relation.ispartofPilot and Feasibility Studies-
dc.titleFeasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial-
dc.typeArticle-
dc.identifier.emailNealon, JAP: jnealon@hku.hk-
dc.identifier.authorityNealon, JAP=rp02917-
dc.identifier.doi10.1186/s40814-022-01044-w-
dc.identifier.hkuros333005-
dc.identifier.volume8-
dc.identifier.issue1-
dc.identifier.spage87-
dc.identifier.epage87-
dc.identifier.isiWOS:000784562400001-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats